Management of patients with ulcerative colitis with account of microbiological examination of bioptate of colon wall

Cover Page

Cite item

Abstract

Ulcerative colitis (UC) is a common disease with the evident tendency to annual increase in incidence. The disease mostly affects young individuals of active working age. The peak of incidence of the disease is observed at the age of 20-29 and 50-55 years.

The aim of study was optimization of diagnostics and management of patients with ulcerative colitis by correction of antibacterial therapy on the basis of the data of microbiological examination of the microflora of the wall of colon.

Materials and Methods. 35 Patients with ulcerative colitis from 28 to 61 years of age with the average age 37.6 years who underwent outpatient and stationary treatment in colonoproctology and gastroenterology departments of SamSMU clinics in the period from January to May 2017 were examined. Of them, 18 were males (48.6%) and 17 females (51.4%).

Results. Significant species diversity of microflora was identified that requires exact species identification and development of standard procedures for isolation of microorganisms from bioptates of patients with ulcerative colitis with the aim of administration of antibacterial treatment. In analysis of sensitivity of the isolated strains to antibiotics 45% of the isolated microorganisms were found to have signs of resistance to 1-2 groups of medical drugs, and 33% showed signs of resistance to 3 and more groups. Only 22% of strains were found to be sensitive to all tested preparations. Eradication of such flora presents certain difficulties, and in our opinion, requires administration of combined therapy after examination of bioptate.

Conclusions. All patients with ulcerative colitis require examination of the microbial composition of the intestinal wall for optimization of diagnostics and treatment. 105-106 titer of microorganisms, their wide species diversity may support inflammation in the colon and prevent relief. It is necessary to continue study of microbiological composition of the colonic wall in the comparative aspect for optimization of diagnostics and management of patients with ulcerative colitis.

About the authors

O. E. Davydova

Samara State Medical University

Author for correspondence.
Email: lichman163@gmail.com
ORCID iD: 0000-0002-2403-1990
SPIN-code: 4100-9553

Proctologist of Clinic and Department of Hospital Surgery

Russian Federation, 171, Artsibyeshevskaya street, Samara, 443001

P. S. Andreev

Samara State Medical University

Email: lichman163@gmail.com
ORCID iD: 0000-0002-0264-7305
SPIN-code: 4564-3449

MD, PhD, Proctologist of Clinic and Department of Hospital Surgery

Russian Federation, 171, Artsibyeshevskaya street, Samara, 443001

S. E. Katorkin

Samara State Medical University

Email: lichman163@gmail.com
ORCID iD: 0000-0001-7473-6692
SPIN-code: 7259-3894

MD, PhD, Associate Professor, Head of the Department of Hospital Surgery

Russian Federation, 171, Artsibyeshevskaya street, Samara, 443001

A. V. Lyamin

Samara State Medical University

Email: lichman163@gmail.com
ORCID iD: 0000-0002-5905-1895
SPIN-code: 6607-8990

MD, PhD, Bacteriologist of Microbiological Department of Surgical Clinic Diagnostic Laboratory

Russian Federation, 171, Artsibyeshevskaya street, Samara, 443001

I. V. Kiseleva

Samara State Medical University

Email: lichman163@gmail.com
ORCID iD: 0000-0002-1493-8695
SPIN-code: 2148-2545

MD, PhD, Head of Consultation and Diagnostic Center of Surgical Clinic

Russian Federation, 171, Artsibyeshevskaya street, Samara, 443001

L. A. Lichman

Samara State Medical University

Email: lichman163@gmail.com
ORCID iD: 0000-0002-4817-3360
SPIN-code: 2380-0840

Surgeon of Surgical Department of Hospital Surgery Clinic

Russian Federation, 171, Artsibyeshevskaya street, Samara, 443001

S. A. Bistrov

Samara State Medical University

Email: lichman163@gmail.com
ORCID iD: 0000-0003-1123-1544
SPIN-code: 6772-4595

MD, PhD, Associate Professor, Head of Surgical Department of Hospital Surgery Clinic

Russian Federation, 171, Artsibyeshevskaya street, Samara, 443001

References

  1. Vorob'ev GI, Khalif IL. Nespetsificheskie vospalitel'nye zabolevaniya kishechnika. Moscow: Miklosh; 2008. (In Russ).
  2. Ivashkin VT, Lapina TL. Gastro-enterologiya: natsional'noe rukovodstvo. Moscow: GEOTAR-Media; 2008. (In Russ).
  3. Komarov FI, Osadchuk AM, Osadchuk MF, et al. Nespetsificheskiy yazvennyy kolit. Moscow: Meditsinskoe informatsionnoe agentstvo; 2008. (In Russ).
  4. Belousova EA. Yazvennyy kolit i bolezn' Krona. Tver: Triada; 2002. (In Russ).
  5. Lyagina IA, Korneva TK, Golovenko OV, et al. Kharakteristika kishechnoy mikroflory u bol'nykh yazvennym kolitom. Rossiyskiy zhurnal gastroenterologii, gepato-logii i koloproktologii. 2008;2:48-54. (In Russ).
  6. Sandler RS, Eisen GM. Epidemiology of inflammatory bowel disease. In: Kirshner JB, editor. Inflammatory bowel disease. 5th edition. Saunders; 2000. P. 89-113.
  7. Zhukov BN, Isaev VR, Andreev PS, et al. Kompleksnoe lechenie nespetsificheskogo yazvennogo kolita s primeneniem endolimfa-ticheskoy terapii. Novosti khirurgii. 2012; 20(2):49-54. (In Russ).
  8. Reid KC, Cockerill FR, Patel R. Clinical and Epidemiological Features of Enterococcus casseli flavus / flavescens and Enterococcus gallinarum Bacteremia: а Report of 20 Cases. Clin Infect Dis. 2001; 32(11):1540-6. doi: 10.1086/320542.
  9. Lyamin AV, Andreev PS, Zhestkov AV, et al. Antibiotikorezistentnost' gramotrit-satel'noy mikroflory, vydelennoy iz biopsiy-nogo materiala u bol'nykh nespetsificheskim yazvennym kolitom. Klinicheskaya mikro-biologiya i antimikrobnaya khimioterapiya. 2010; 12(4):342-6. (In Russ).
  10. Truelove SC. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955; 2:1041-8.
  11. Davydova OE, Andreev PS, Katorkin SE. Yazvennyy kolit – osobennosti diagnostiki i lecheniya. Nauchno-praktiches-kiy zhurnal gastroenterologiya Sankt-Peter-burga. 2017; 1:76-7. (In Russ).
  12. Davydova OE, Katorkin SE, Lyamin AV, et al. Uluchshenie rezul'tatov lecheniya patsientov s yazvennym kolitom s ispol'zovaniem individual'nykh skhem eradi-katsionnoy terapii uslovno-patogennoy mik-roflory, osnovannykh na mikrobiologiches-kom monitoring. Vrach-aspirant. 2016; 77(4):49-55. (In Russ).

Copyright (c) 2018 Davydova O.E., Andreev P.S., Katorkin S.E., Lyamin A.V., Kiseleva I.V., Lichman L.A., Bistrov S.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies